- Recommendation ID
NICE encourages further research into radiofrequency ablation for symptomatic Morton's neuroma. Further research should include details of patient selection and previous treatments. Studies should compare the procedure against other non-surgical treatments, such as steroid injections.
Outcome measures should include pain relief, the duration of treatment effect, and the need for subsequent treatments.
- Any explanatory notes
Current evidence on radiofrequency ablation for symptomatic interdigital (Morton's) neuroma raises no major safety concerns. The evidence on efficacy is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research.
Source guidance details
- Comes from guidance
- Radiofrequency ablation for symptomatic interdigital (Morton’s) neuroma
- Date issued
- December 2015
|Is this a recommendation for the use of a technology only in the context of research?||Yes|
|Is it a recommendation that suggests collection of data or the establishment of a register?||No|